Moreover, TP53-mediated SREBP2 cholesterol synthesis can also enhance the prenylation of Rho GTPases, which, in turn, enhance the proliferation and self-renewal of breast cancer cells [54,63]. Here, TP53 is linked to breast carcinoma.